Spots Global Cancer Trial Database for primary amyloidosis
Every month we try and update this database with for primary amyloidosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis | NCT00883623 | Primary Amyloid... | Lenalidomide | 18 Years - 74 Years | Heidelberg University | |
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden | NCT00651937 | Multiple Myelom... Primary Amyloid... | Melphalan Stem Cell Infus... Questionnaires Granulocyte-col... Apheresis | 60 Years - | M.D. Anderson Cancer Center | |
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis | NCT02555969 | Amyloidosis Primary Amyloid... | - | Tufts Medical Center | ||
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis | NCT02555969 | Amyloidosis Primary Amyloid... | - | Tufts Medical Center | ||
Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis | NCT01707264 | Primary Amyloid... | NEOD001 | 18 Years - | Prothena Biosciences Ltd. |